FDA Inspection 754930 — Richard De La Garza, II, Ph.D

Richard De La Garza, II, Ph.D — FEI 3009139723

The FDA completed an inspection of Richard De La Garza, II, Ph.D on January 23, 2012 in Houston, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 23, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752621 CFR 312.62(a)Accountability records
756021 CFR 312.60FD-1572, protocol compliance